Acute (single dose / short-term)

• GI upset / nausea / metallic taste: very common at ≥30 mg fasted. Mitigation: take with food, switch from picolinate to bisglycinate (gentler on most stomachs).
• Headache, drowsiness: less common.
• Lozenge-specific: dysgeusia (metallic/bitter aftertaste), oral irritation, dry mouth — Hunter 2021 meta-analysis flagged these as the main tolerability limit.

Subacute (weeks)

• Reduced HDL cholesterol: documented at supraphysiologic doses (>50 mg/day chronic).
• Iron absorption interference: matters if you're managing low ferritin. Space zinc and iron by 4 hours.
• Suppressed immune cell function paradox: at chronic doses >150 mg/day, zinc impairs T-cell function — the U-shape is real.

Chronic (months)

• Zinc-induced copper deficiency — the headline chronic risk. Mechanism: zinc upregulates enterocyte metallothionein, which binds copper more avidly than zinc; the bound copper is sloughed off in enterocyte turnover. Consequences:
  • Hypochromic, microcytic or normocytic anemia — looks like iron deficiency on CBC.
  • Neutropenia — frequent infections paradox.
  • Copper-deficiency myeloneuropathy — gait ataxia, distal paresthesias, sensory ataxia. Crucially: only ~24% of cases recover neurologically even with copper repletion, and only ~5% return fully to baseline (per 2024 systematic review of CDM). This is the irreversible-harm scenario.
  • Risk doses: >50 mg/day for >6 months without copper is dangerous; case reports exist at 100–150 mg/day over years (denture-cream cases, Wilson's-disease over-treatment). Death is rare but morbidity is meaningful.
• Mitigation rule (non-negotiable): any zinc dose >25 mg/day chronic → pair 1–2 mg copper at a ~15:1 zinc:copper ratio. The NAS UL of 40 mg/day was set specifically to prevent this (Wuehler 2022 review, PMID 35565906, revisits and largely upholds the threshold).

Specific watch periods (this archetype)

• Month 3: First CBC + serum zinc + serum copper + ceruloplasmin if maintaining >25 mg/day chronic. Hb, MCV, neutrophil count flag early copper depletion.
• Month 6+: Recheck if continuing high dose; otherwise annual.
• Anytime: new gait ataxia, paresthesias, or persistent anemia → stop zinc, check copper, neurology referral if persistent.